How to Improve PVSA Compliance Rates
Higher PVSA compliance rates lead to better clinical outcomes, enhancing the laboratory’s reputation and value to healthcare providers.
Read MorePosted by Chris Wolski | Feb 6, 2025 | Urinalysis & Toxicology |
Higher PVSA compliance rates lead to better clinical outcomes, enhancing the laboratory’s reputation and value to healthcare providers.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Chris Wolski | Jan 15, 2025 | Miscellaneous |
Following a People-to-People trip to Cuba, CLP Chief Editor Chris Wolski gained a more nuanced view of the Cuban healthcare system.
Read MorePosted by Andy Lundin | Dec 20, 2024 | Molecular Diagnostics, Pancreatic |
PharusDx announced a liquid biopsy test that uses microRNA and CA19-9 biomarkers to detect early-stage pancreatic cancer.
Read MorePosted by Andy Lundin | Dec 9, 2024 | Diabetes & Metabolic Diseases |
Researchers have identified two types of metabolic-associated fatty liver disease (MASLD), offering insights for improved diagnosis.
Read More